Literature DB >> 20056393

Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.

Joel Stoddard1, Tara Niendam, Robert Hendren, Cameron Carter, Tony J Simon.   

Abstract

Thirty percent of individuals with chromosome 22q11.2 deletion syndrome (22q11.2DS) develop a psychotic disorder, particularly schizophrenia. We assessed attenuated positive, negative and disorganized symptoms of psychosis and clinical-high-risk syndromes in 20 adolescents with 22q11.2DS (median age 15.1 years) using the Structured Interview for Prodromal Symptoms (SIPS). Two participants met criteria for the Attenuated Positive Symptom Syndrome, while nine participants (45%) experienced positive symptoms rated in the "moderate" to "severe and psychotic" range on the SIPS. Almost all presented with moderate to severe symptoms in the negative, disorganized, and general symptom domains. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20056393      PMCID: PMC2856801          DOI: 10.1016/j.schres.2009.12.011

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  14 in total

1.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

2.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.

Authors:  J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-07       Impact factor: 8.829

3.  Performance on the Modified Card Sorting Test and its relation to psychopathology in adolescents and young adults with 22q11.2 deletion syndrome.

Authors:  K Rockers; O Ousley; T Sutton; E Schoenberg; K Coleman; E Walker; J F Cubells
Journal:  J Intellect Disabil Res       Date:  2009-05-12

Review 4.  Velo-cardio-facial syndrome: a model for understanding the genetics and pathogenesis of schizophrenia.

Authors:  K C Murphy; M J Owen
Journal:  Br J Psychiatry       Date:  2001-11       Impact factor: 9.319

Review 5.  Symptom assessment in schizophrenic prodromal states.

Authors:  T J Miller; T H McGlashan; S W Woods; K Stein; N Driesen; C M Corcoran; R Hoffman; L Davidson
Journal:  Psychiatr Q       Date:  1999

6.  Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna Lifshey Rosen; Lubna Somjee; Philip J Markovich; Kelly Stein; Scott W Woods
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

7.  Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group.

Authors:  Kate D Baker; David H Skuse
Journal:  Br J Psychiatry       Date:  2005-02       Impact factor: 9.319

8.  Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk.

Authors:  Carl Feinstein; Stephan Eliez; Christine Blasey; Allan L Reiss
Journal:  Biol Psychiatry       Date:  2002-02-15       Impact factor: 13.382

Review 9.  Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome.

Authors:  Doron Gothelf; Marie Schaer; Stephan Eliez
Journal:  Dev Disabil Res Rev       Date:  2008

10.  Global assessment of functioning. A modified scale.

Authors:  R C Hall
Journal:  Psychosomatics       Date:  1995 May-Jun       Impact factor: 2.386

View more
  34 in total

1.  Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice.

Authors:  Michael Didriksen; Kim Fejgin; Simon R O Nilsson; Michelle R Birknow; Hannah M Grayton; Peter H Larsen; Jes B Lauridsen; Vibeke Nielsen; Pau Celada; Noemi Santana; Pekka Kallunki; Kenneth V Christensen; Thomas M Werge; Tine B Stensbøl; Jan Egebjerg; Francois Gastambide; Francesc Artigas; Jesper F Bastlund; Jacob Nielsen
Journal:  J Psychiatry Neurosci       Date:  2017-01       Impact factor: 6.186

2.  Social cognitive training in adolescents with chromosome 22q11.2 deletion syndrome: feasibility and preliminary effects of the intervention.

Authors:  V Shashi; W Harrell; S Eack; C Sanders; A McConkie-Rosell; M S Keshavan; M J Bonner; K Schoch; S R Hooper
Journal:  J Intellect Disabil Res       Date:  2015-04-14

3.  Subthreshold psychotic symptoms in 22q11.2 deletion syndrome.

Authors:  Sunny X Tang; James J Yi; Tyler M Moore; Monica E Calkins; Christian G Kohler; Daneen A Whinna; Margaret C Souders; Elaine H Zackai; Donna M McDonald-McGinn; Beverly S Emanuel; Warren B Bilker; Ruben C Gur; Raquel E Gur
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-06-19       Impact factor: 8.829

4.  Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated.

Authors:  S X Tang; J J Yi; M E Calkins; D A Whinna; C G Kohler; M C Souders; D M McDonald-McGinn; E H Zackai; B S Emanuel; R C Gur; R E Gur
Journal:  Psychol Med       Date:  2013-09-09       Impact factor: 7.723

Review 5.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

6.  Disrupted fornix integrity in children with chromosome 22q11.2 deletion syndrome.

Authors:  Yi Deng; Naomi J Goodrich-Hunsaker; Margarita Cabaral; David G Amaral; Michael H Buonocore; Danielle Harvey; Kristopher Kalish; Owen T Carmichael; Cynthia M Schumann; Aaron Lee; Robert F Dougherty; Lee M Perry; Brian A Wandell; Tony J Simon
Journal:  Psychiatry Res       Date:  2015-02-11       Impact factor: 3.222

7.  Response to clozapine in a clinically identifiable subtype of schizophrenia.

Authors:  Nancy J Butcher; Wai Lun Alan Fung; Laura Fitzpatrick; Alina Guna; Danielle M Andrade; Anthony E Lang; Eva W C Chow; Anne S Bassett
Journal:  Br J Psychiatry       Date:  2015-03-05       Impact factor: 9.319

Review 8.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

Review 9.  Bullying and psychosis: The impact of chronic traumatic stress on psychosis risk in 22q11.2 deletion syndrome - a uniquely vulnerable population.

Authors:  Danessa Mayo; Khalima A Bolden; Tony J Simon; Tara A Niendam
Journal:  J Psychiatr Res       Date:  2019-04-15       Impact factor: 4.791

10.  The hippocampi of children with chromosome 22q11.2 deletion syndrome have localized anterior alterations that predict severity of anxiety.

Authors:  Julia A Scott; Naomi Goodrich-Hunsaker; Kristopher Kalish; Aaron Lee; Michael R Hunsaker; Cynthia M Schumann; Owen T Carmichael; Tony J Simon
Journal:  J Psychiatry Neurosci       Date:  2016-04       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.